Editor(s):
(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.
Reviewers:
(1) Taimi Amakali-Nauiseb, University of Namibia, Namibia.
(2) David Oliver, University of Kent, UK.
(3) Hassan Soleimanpour, Tabriz University of Medical Sciences, Iran.
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.23/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (Taimi Amakali-Nauiseb, Namibia) | File 1 | NA
Stage 2 | Peer Review Report_2 (David Oliver, UK) | File 1 | NA
Stage 2 | Peer Review Report_3 (Hassan Soleimanpour, Iran) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 2 | Re-Review report_2_v1 (David Oliver, UK) | File 1 | NA
Stage 2 | Re-Review report_3_v1 (Hassan Soleimanpour, Iran) | File 1 | NA
Stage 2 | Revised_MS_v2_and_Feedback_v2 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA